Cryptococcosis

Clinics in Dermatology

Volumn 30, Issue 6, 2012, Pages 599-609

  Negroni, Ricardo ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ARTICLE; BRAIN SURGERY; CENTRAL NERVOUS SYSTEM CRYPTOCOCCOSIS; CLINICAL FEATURE; CRYPTOCOCCOSIS; CUTANEOUS CRYPTOCOCCOSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FUNGAL VIRULENCE; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INFECTION PREVENTION; LUNG SURGERY; OCULAR CRYPTOCOCCOSIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PULMONARY CRYPTOCOCCOSIS; TREATMENT INDICATION;

EID: 84867587922     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2012.01.005     Document Type: Note

References (43)

1. Palmieri O.J., Corti M.E., Laube G.E., et al. Enfermedades Infecciosas 2009, 591-596. Buenos Aires, OJ Palmieri. 3rd ed.
2. Negroni R. Criptococosis. Sida y Enfermedades Asociadas. Diagnóstico, Clínica y Tratamiento 2008, 332-336. FUNDAI, Buenos Aires. 3rd ed. J. Benetucci (Ed.).
3. Viviani M.A., Tortorano A.M. Cryptococcosis. Clinical mycology 2009, 231-249. Churchill Livingstone Elsevier, New York. 2nd ed. E.J. Anaisse, M.R. Mc Ginnis, M.A. Pfaller (Eds.).
4. Baddley J.W., Dismukes W.E. Cryptococcosis. Medical mycology 2003, 188-205. Oxford University Press, Oxford. W.E. Dismukes, P.G. Pappas, J.D. Sobel (Eds.).
5. Kwon-Chung K.L., Bennett J.E. Cryptococcosis. Medical mycology 1992, 397-446. Lea & Febiger, Philadelpia. K.L. Kwon-Chung, J.E. Bennett (Eds.).
6. Casadevall A., Perfect J. Crytococcus neoformans 1998, ASM Press, Washington, DC.
7. Arechavala A.I., Robles A.M., Negroni R., et al. Valor de los métodos directos e indirectos de diagnóstico en las micosis sistémicas asociadas al sida. Rev Inst Méd Trop São Paulo 1993, 35:163-169.
8. Salfelder K., de Liscano T.R., Sauerteig E. Cryptococcosis. Atlas of fungal pathology 1990, 60-72. Kluwer Academic Publishers, Boston.
9. Chayakulkeeree M., Perfect J.R. Crytococcosis. Infect Dis Clin N Am 2006, 20:507-544.
10. Perfect J., Casadevall A. Cryptococcosis. Infect Dis N Am 2002, 16:837-874.
11. Bava A.J., Negroni R., Arechavala A., et al. Cryptococcosis associated with AIDS in the Muñiz Hospital of Buenos Aires. Mycopathologia 1997, 140:13-17.
12. Arechavala A.I. Métodos de Diagnóstico de la Criptococosis Asociada al SIDA. Tesis de Doctorado. Facultad de Medicina 1998, Universidad de Buenos Aires, Buenos Aires.
13. Huston S.M., Mody C.H. Cryptococcosis: an emerging respiratory mycosis. Clin Chest Med 2009, 30:253-264.
14. de Queiroz-Telles F., Moretti-Bianchini M.L. Criptococose. Condutas em Infectologia 2004, 367-375. Atheneu, Sao Paulo. S. Cimerman, B. Cimerman (Eds.).
15. Kidd S.E., Chow Y., Mak S., et al. Characterization of environmental sources of human pathogen Cryptococcus gattii in British Columbia Canada and the Pacific Northwest of the United States. Appl Environ Microbiol 2007, 73:1433-1443.
16. Nucci M., Queiroz-Telles F., Tobón A., et al. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010, 51:561-570.
17. Mac Douglas L., Fyfe M., Rommey M., et al. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 2011, 17:193-199.
18. Kidd S.E., Guo H., Bartlett K.H., et al. Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot Cell 2005, 4:1629-1638.
19. Singh N., Alexander B., Lortholary O., et al. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008, 46:e12-e18.
20. Corrêa Mdo P., Oliveira E.C., Duarte R.R., et al. Criptococose em crianças no Estado do Pará, Brasil. Rev Soc Bras Méd Trop 1999, 32:505-508.
21. Arechavala A., Baiges D., Negroni R., et al. Study of some lymphocyte subset counts and cytokines levels in cryptococcosis associated with AIDS. Rev Iberoamer Micol 1997, 20:24-28.
22. Wilson W., Plunkett O.A. Cryptococcosis. The fungous diseases of man 1965, 111-119. University of California Press B, Berkeley. W. Wilson, O.A. Plunkett (Eds.).
23. Elewski B., Radentz W.H., Gupta A.K. Opportunistic mycoses. Cutaneous fungal infections 1998, 225-259. Blackwell Science, Cambridge. 2nd ed. B. Elewski (Ed.).
24. Corti M., Trione N., Semorile K., et al. Neumonía cavitaria por Cryptococcus neoformans en um paciente com SIDA. Rev Iberoam Micol 2008, 25:65-69.
25. Helou S., Robles A.M., Arechavala A.I., et al. Criptococosis respiratória em pacientes VIH positivos. Rev Iberoamer Micol 1999, 16:126-129.
26. Negroni R., Arechavala A., Robles A.M., et al. Revisión clínica y evolución terapéutica de pacientes con criptococosis asociada al SIDA. Rev Iberoamer Micol 1995, 12:12-15.
27. Corti M., Villafañe M.F., Negroni R., et al. Magnetic resonante imaging finding in AIDS patients with central nervous system cryptococcosis. Rev Iberoam Micol 2008, 25:211-214.
28. Metta H.A., Corti M.E., Negroni R., et al. Criptococcosis diseminada en pacientes con SIDA. Análisis clínico, microbiólogo e inmunológico de 51 pacientes. Revista Argentina de Microbiología 2002, 34:117-123.
29. Powderly W.G. Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996, 22(Suppl 2):119-127.
30. Bava A.J., Arechavala A.I., Robles A.M., et al. Pronóstico de la criptococosis asociadas al SIDA a través de algunas pruebas de laboratorio. Rev Argent Infectol 1999, 12:3-7.
31. Corti M., Solari R., Cangelosi D., et al. Sudden blindness due to bilateral optic neuropathy associated with cryptococcal meningitis in an AIDS patient. Rev Iberoam Micol 2010, 27:207-209.
32. Negroni R., Arechavala A., Maiolo E., et al. Problemas clínicos en micología médica. Problema n° 40. Rev Iberoam Micol 2010, 27:148-150.
33. Bianchi M.H., Robles A.M., Vitale R., et al. The usefulness of blood cultures in diagnosing HIV-related systemic mycoses: evaluation of a manual lysis- centrifugation method. Med Mycol 2000, 38:77-80.
34. Nguyen M.H., Clancy J., Husain S. Cryptococcus neoformans (cryptococcosis). Antimicrobial therapy and vaccines 2002, 1045-1057. Apple Tree Productions, LLC, New York. 2nd ed. V. Yu, R. Weber, D. Raoult (Eds.).
35. Perfect J., Dismukes W.E., Dromer F., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:291-322.
36. Pitisuttithum P., Negroni R., Graybill J.R., et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005, 56:745-755.
37. Quindós G., del Palacio A., Pontón J. Presente y futuro del voriconazol en el tratamiento de las micosis invasoras. Rev Iberoamer Micol 2007, 24:179-234.
38. Graybill J.R., Sobel J., Saag M., et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000, 30:47-54.
39. Mussini C., Pezzotti P., Miro J.M., et al. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy. An international observational study. Clin Infect Dis 2004, 38:565-571.
40. Negroni R., Helou S.H., López Daneri G., et al. Interrupción exitosa de la profilaxis secundaria antifúngica en la criptococosis asociada al SIDA. Rev Argent Microbiol 2004, 36:113-117.
41. Antela Lopez A., Callegari Costa L., Dalla Negra M., et al. Pautas para la prevención de infecciones oportunistas en personas con VIH o sida en América Latina y el Caribe 2003, Organización Panamericana de la Salud, Montevideo, Uruguay.
42. Ajello L. The medical mycology iceberg. In: Pan American Health Organization, Proceeding of the International Symposium on the Mycoses, Washington, DC 1970, 3-12.
43. Kaufman L., Blumer S. Cryptococcosis: the awakening giant. In: Pan American Health Organization, Proceedings of the IV International Conference on the Mycoses, Washington, DC 1978, 176-182.